Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 8:9:841112.
doi: 10.3389/fmed.2022.841112. eCollection 2022.

Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome

Affiliations

Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome

Hang Song et al. Front Med (Lausanne). .

Abstract

Purpose: To analyze the conjunctival sac microbial communities in patients with Sjögren's syndrome-associated dry eyes (SSDE) and non-Sjögren's syndrome-associated dry eyes (NSSDE), compared with normal controls (NC).

Methods: Conjunctival sac swab samples from 23 eyes of SSDE, 36 eyes of NSSDE, and 39 eyes of NC were collected. The V3-V4 region of the 16S ribosomal RNA (rRNA) gene high-throughput sequencing was performed on an Illumina MiSeq platform and analyzed using Quantitative Insights Into Microbial Ecology (QIIME). Alpha diversity was employed to analyze microbiome diversity through Chao1 and Shannon indexes. Beta diversity was demonstrated by the principal coordinates analysis (PCoA) and Partial Least Squares Discrimination Analysis (PLS-DA). The relative abundance was bioinformatically analyzed at the phylum and genus levels.

Results: The alpha diversity was lower in patients with dry eye disease (Shannon index: NC vs. SSDE: P = 0.020, NC vs. NSSDE: P = 0.029). The beta diversity showed divergent microbiome composition in different groups (NC vs. SSDE: P = 0.001, NC vs. NSSDE: P = 0.001, NSSDE vs. SSDE: P = 0.005). The top 5 abundant phyla were Firmicutes, Proteobacteria, Actinobacteriota, Bacteroidota, and Cyanobacteria in all three groups. The top five abundant genera included Acinetobacter, Staphylococcus, Bacillus, Corynebacterium, and Clostridium_sensu_stricto_1. The relative microbiome abundance was different between groups. The Firmicutes/Bacteroidetes (F/B) ratio was 6.42, 7.31, and 9.71 in the NC, NSSDE, and SSDE groups, respectively (NC vs. SSDE: P = 0.038, NC vs. NSSDE: P = 0.991, SSDE vs. NSSDE: P = 0.048).

Conclusion: The diversity of conjunctival sac microbiome in patients with NSSDE and SSDE was diminished compared with NC. The main microbiome at the phylum and genus level were similar between groups, but the relative abundance had variations. The Firmicutes/Bacteroidetes ratio was higher in the SSDE group.

Keywords: Sjögren's syndrome; dry eyes; microbial composition; microbial diversity; ocular surface.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Alpha analysis by Shannon (A) and Chao1 (B) indexes demonstrating that patients with dry eyes have diminished ocular surface microbiome diversity compared with patients with healthy ocular surfaces.
Figure 2
Figure 2
Beta diversity demonstrated by principal coordinates analysis (PCoA) (A) and Partial Least Squares Discrimination Analysis (PLS-DA) (B) analysis. Samples in the control group were more centralized and resembled each other in the bacterial composition, while samples in the non-Sjögren's syndrome-associated dry eyes (NSSDE) and Sjögren's syndrome-associated dry eyes (SSDE) groups were more acentric and disperse.
Figure 3
Figure 3
The top five abundant microbiomes at the phylum (A) and genus (B) level showed similar major components of bacteria in each group, but the relative abundance was different.
Figure 4
Figure 4
The top 20 significantly different microbiomes at the phylum (A) and genus (B) level.

Similar articles

Cited by

References

    1. Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Deutsches Arzteblatt Int. (2015) 112:71–81. 10.3238/arztebl.2015.0071 - DOI - PMC - PubMed
    1. Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Benítez-del-Castillo J, et al. . Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. (2016) 100:300–6. 10.1136/bjophthalmol-2015-307415 - DOI - PMC - PubMed
    1. O'Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. Curr Opin Ophthalmol. (2019) 30:166–78. 10.1097/ICU.0000000000000569 - DOI - PMC - PubMed
    1. Buckley RJ. Assessment and management of dry eye disease. Eye. (2018) 32:200–3. 10.1038/eye.2017.289 - DOI - PMC - PubMed
    1. Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjögren's syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int J Med Sci. (2017) 14:191–200. 10.7150/ijms.17718 - DOI - PMC - PubMed

LinkOut - more resources